Papers
3
Total Citations
52
H-Index
3
About
Dr. Larry J. Copeland is a pioneering gynecologic oncologist whose research has fundamentally shaped surgical standards for cervical and endometrial cancers. His most transformative work centers on the critical comparison between robotic and open surgical approaches, particularly following the paradigm-shifting LACC trial. Dr. Copeland led the landmark ROCC/GOG-3043 trial (2022, 24 citations), a randomized non-inferiority study that rigorously evaluated robotic versus open radical hysterectomy for early-stage cervical cancer, directly addressing safety concerns raised by earlier laparoscopic studies. His prospective comparative study (2016, 20 citations) further advanced the field by demonstrating that robotic hysterectomy for endometrial cancer staging offers superior postoperative pain control and quality of recovery compared to open surgery. With the recent publication of ROCC/GOG-3043’s full results (2025, 8 citations), Dr. Copeland continues to provide definitive evidence guiding surgical decision-making. His work has been instrumental in validating robotic techniques while ensuring oncologic safety, earning him recognition as a leader in minimally invasive gynecologic oncology. Through these high-impact studies, Dr. Copeland has directly influenced clinical guidelines and improved perioperative outcomes for thousands of women worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3